903 results on '"van der Veen, Fulco"'
Search Results
202. Reducing Inter-Laboratory Differences between Semen Analyses Using Z Score and Regression Transformations.
203. HIV couples' anxiety and risk taking during ART
204. CAG repeat length variation in the Androgen Receptor gene is not associated with spermatogenic failure
205. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome
206. Ectopic pregnancy: how the diagnostic and therapeutic management has changed
207. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely
208. Mild ovarian stimulation in women with poor ovarian response undergoing IVF and ICSI
209. Reply of the Authors
210. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis
211. Severe maternal morbidity in ectopic pregnancy is not associated with maternal factors but may be associated with quality of care
212. Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation
213. Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model
214. Comment on GnRH analogue cotreatment with chemotherapy for preservation of ovarian function
215. Metformin co-administration during follicle stimulating hormone ovulation induction with timed intercourse or intra-uterine insemination for subfertility associated with polycystic ovary syndrome
216. Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review of the best available evidence
217. Prognostic value of the postcoital test for spontaneous pregnancy
218. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
219. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles
220. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
221. Identification of barriers for good adherence to a guideline on recurrent miscarriage
222. Reproducibility and reliability of repeated semen analyses in male partners of subfertile couples
223. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
224. Aspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage
225. The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial
226. 724: Cost-effectiveness of chromosome analysis in couples with recurrent miscarriage to prevent the birth of handicapped offspring
227. The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility
228. Immunoglobulin G antisperm antibodies and prediction of spontaneous pregnancy
229. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
230. Culture media for human preimplantation embryos in assisted reproductive technology cycles
231. Oocyte vitrification—Women's emancipation set in stone
232. Effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomized clinical trial
233. Preferences of subfertile women regarding elective single embryo transfer: additional in vitro fertilization cycles are acceptable, lower pregnancy rates are not
234. Chlamydia antibody titer testing versus hysterosalpingography for detection of tubal pathology in subfertile women
235. Predictive value of pregnancy history in subfertile couples: results from a nationwide cohort study in the Netherlands
236. Semen quality remains stable during 96 weeks of untreated human immunodeficiency virus-1 infection
237. Benefits of PGD in patients with recurrent miscarriages?
238. Effects of antiretroviral therapy on semen quality
239. The additional value of ovarian hyperstimulation in intrauterine insemination for couples with an abnormal postcoital test and a poor prognosis: a randomized clinical trial
240. In Vitro Fertilization With Preimplantation Genetic Screening
241. Semen Quality and Drug Concentrations in Seminal Plasma of Patients Using a Didanosine or Didanosine Plus Tenofovir Containing Antiretroviral Regimen
242. Predictive Value and Clinical Impact of Basal Follicle-Stimulating Hormone in Subfertile, Ovulatory Women
243. Preimplantation genetic screening as an alternative to prenatal testing for Down syndrome: preferences of women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment
244. The role of metformin in polycystic ovary syndrome: a systematic review
245. External validation of a prediction model for an ongoing pregnancy after intrauterine insemination
246. Reply: Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples
247. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles
248. Interventions for tubal ectopic pregnancy
249. Intrauterine insemination in The Netherlands
250. Patients' preferences for intrauterine insemination or in-vitro fertilization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.